SEE ALSO: The massive $500 billion budget deal could be coming at exactly the wrong time for the economy » READ …
I initiated a position in GSK recently. The stock is attractively priced, partly due to currency effects, and the weak pound will continue to be a tailwind for the business. The company returned to growth, but it needs to gain more momentum. …
Portfolio Grader currently ranks GlaxoSmithKline Plc (NYSE:GSK) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental …
At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain for the new May 2018 contracts and identified one put and one call contract of particular interest. The put contract at the $37.00 strike price …
Nasdaq5mon
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
GlaxoSmithKline (GSK) expects its adjusted profit to slide ... IBD'S TAKE: The …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
Glaxo's rise in May was precipitated by two catalysts. First, the drugmaker's new managerial team, headed by CEO Emma Walmsley (who took over in March), has been indicating that they might be open to accelerating the company's …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …